Turning investment into NHS impact: EBO’s next chapter

3 November, 2026

For someone waiting for an appointment, a simple question can carry a great deal of importance. When will I be seen? Where do I need to go? Is there something I should do beforehand? Can I reschedule? Making it easier to find those answers and making healthcare more accessible and inclusive, has been the driving force behind EBO’s work in healthcare.

London-based AI company EBO, now serves 23 organisations across NHS trusts, hospitals, community interest companies (CICs) and integrated care boards (ICBs). Having secured investment from Olea Venture Partners, EBO is building on that experience with further international growth and developing its technology, with particular focus on its AI-powered Intelligent Patient Portal. Here, founder and CEO Dr. Gege Gatt, reflects on the company’s progress, the future of AI in healthcare and what this means for UK healthcare providers.

Dr. Harietta Eleftherochorinou, Founding and Managing Partner at Olea Venture Partners and Dr. Gege Gatt, Founder and CEO of EBO

Gege, how would you describe the stage EBO has reached today?

We have reached a stage where our experience in delivering AI within complex environments provides a strong foundation for further growth. EBO began with a simple conviction: interacting with essential services should be as natural as having a conversation. We have since developed that vision into an enterprise AI platform that goes beyond answering questions. Our technology connects patients to information, systems and workflows, enabling them to complete tasks while automating the administrative processes behind those interactions.

This translates into better patient access, more efficient services and valuable time released for clinical teams. Our experience working across NHS trusts, hospitals, CICs and ICBs has given us a deep understanding of the operational complexity of healthcare delivery. Central to this is interoperability, both upstream and downstream.

Upstream, our solution connects seamlessly with existing NHS infrastructure, including electronic patient record (EPR) systems, the NHS App and other clinical platforms, to access relevant information and context. Downstream, it translates patient interactions into meaningful actions, updating records, triggering workflows and automating processes. This end-to-end integration is fundamental to delivering measurable operational value.

What gives me confidence is the combination of that experience, the capabilities of our team and the evidence emerging from our deployments. We are building on an established base, with a clearer understanding of where we can make a difference and how to extend that impact.

What does the investment from Olea Venture Partners represent for the company?

It represents confidence in EBO and the opportunity ahead, especially because it comes from a partner who understands how innovation becomes trusted practice within health systems.

Olea brings specialist healthcare and life sciences expertise, alongside experience in health-system partnerships, commercial strategy and international expansion.

The investment will help us accelerate adoption across health systems, expand into new clinical and operational workflows, and support growth across Europe and into the United States. It specifically strengthens the next stage of our healthcare growth.

As AI suppliers grow and attract investment, what should NHS customers expect that investment to deliver for them?

They should expect it to strengthen the things that matter to them: the quality of the technology, the support behind implementation and ongoing support, and the supplier’s ability to deliver sustained value through greater efficiency and time savings. For an NHS leader, the relevance of an investment lies in what it enables the organisation to achieve for its patients and staff.

For EBO, that means building on the experience of our existing deployments and bringing further capabilities to the services we support. As we develop the platform, we remain committed to the interoperability, governance and adoption standards that healthcare demands. Critically, clinical safety must remain embedded throughout the technology lifecycle, supported by rigorous risk assessment, appropriate clinical oversight and established NHS clinical safety standards. Growth must translate into better services without compromising the trust and safety on which patient care depends.

Some members from the EBO team at EBO Headquarters

With AI increasingly embedded in healthcare technology, what distinguishes EBO’s approach, and how does that translate into value for patients and healthcare teams?

We have built our approach around the realities of delivering services. In healthcare, a useful conversation must connect users to the right information, systems and actions that allow someone to move forward in their care. That means understanding the whole journey, from the patient’s initial question to the operational process behind the response.

Our platform brings together natural, two-way dialogue, workflow automation and integration with clinical systems. Behavioural science shapes how we communicate, helping us design interactions that are intuitive and responsive to different needs. Governance, safety and human oversight are equally central to how the technology is applied.

The results provide an indication of what that approach can achieve.

Within our UK NHS deployments, we have reported reductions in missed appointments of up to 30% and patient satisfaction of 94%. The underlying value is clear: more accessible services and operational capacity released for healthcare teams.

As we grow, we want to preserve the discipline behind those results. It begins with understanding the problem deeply, working with the organisation to improve the journey and using AI to support that better service.

EBO has established a subsidiary in Greece. How does this fit into your international ambitions?

EBO Greece is an important part of building the connections that will support our next stage of development. It serves as a hub for a South-Eastern Mediterranean cluster of AI expertise, linking our work across Greece, Italy, Cyprus and Malta with our established research and development capabilities in the UK and the US.

International growth depends on bringing research, technology development and implementation closer together. This presence provides a framework for strengthening those relationships across our footprint and building on the expertise we have developed.

The goal is to build a repeatable model for expansion that carries forward our strengths while respecting the environment in which each organisation operates.

How important is integration to that growth?

Interoperability is fundamental to delivering value in healthcare. Organisations have made substantial commitments to their existing systems, and patient engagement technology needs to work effectively within that infrastructure.

EBO integrates with a range of EPR systems. Our most recent assured integration connects our Intelligent Patient Portal with Enlivio Health’s EMIS Community and EMIS Clinical, supporting appointment management workflows alongside NHS login and NHS App functionality.

For patients, the aim is a simpler route to interacting with their care – whatever the underlying data platform is. For healthcare teams, it is about connecting those interactions with established workflows and reducing administrative effort.

Integration helps turn an accessible digital experience into something operationally useful.

What should NHS organisations look for when assessing whether an AI solution will work effectively with their EPR and the NHS App?

Start with the patient journey and the workflow the organisation wants to improve. Which information does the solution need to access? What actions should a patient be able to complete? How will those actions be reflected in the clinical system, and what will staff need to do afterwards? Those questions help establish whether an integration will deliver the intended benefit in practice.

NHS leaders should ask suppliers to demonstrate the specific functions supported, the scope of any technical assurance and how identity and access are managed. They should also understand how exceptions are handled, where human involvement is needed and who is responsible for maintaining the integration as systems evolve. Critically, interoperability should not be treated as a one-off technical achievement, but as a foundation for continuous improvement. This is particularly important with AI, where ongoing monitoring, learning and refinement are essential to improving performance, maintaining clinical safety and delivering sustained value as patient needs and healthcare services evolve.

CSH Surrey’s launch of EBO’s Intelligent Patient Portal has been described as a first for a social enterprise delivering NHS community services. What does this demonstrate?

CSH Surrey has introduced EBO’s Intelligent Patient Portal starting with its podiatry service, giving patients access to appointment and visit information, with a conversational AI assistant available around the clock to answer appointment-related questions. The portal integrates with EMIS and the NHS App.

This makes CSH Surrey the first social enterprise delivering NHS community services to connect its patient appointments via the NHS App.

It is a further step in extending this model of engagement across the different organisations that provide NHS care.

The phased rollout also illustrates EBO’s agile approach and how services can develop in phases. Appointment viewing and information support are available now, with booking, rescheduling and cancellation planned for the next phase. Each stage builds on the patient journey and the processes required to support it.

EBO’s Intelligent Patient Portal for CSH Surrey

What is the wider ambition behind EBO’s Intelligent Patient Portal?

The ambition is to make engagement with healthcare more accessible and effective. People need to understand information, complete tasks and stay connected with their care. Our Intelligent Patient Portal brings conversational AI together with portal functionality to support those needs through the NHS App or a provider’s website.

Depending on the deployment, it can support appointment management, waiting list validation, assessments and personalised care journeys. It also supports more than 100 languages, voice interaction and dialogue designed for different reading levels, helping address barriers that can make digital services difficult to use.

We see this as a way of strengthening the relationship between a person and their healthcare service. By making routine interactions easier to understand and complete, it can support greater participation in care while helping teams manage the work behind those interactions.

NVIDIA, one of the world's most valuable technology companies, has recently accepted EBO into its Inception programme. What does this recognition mean for EBO and its future AI ambitions?

Joining the NVIDIA Inception is an important milestone for EBO and an opportunity to accelerate our technological ambitions.

It gives us access to a global ecosystem of expertise, developer tools and resources as we continue developing robust, clinically safe and well-governed AI for healthcare.

One of our immediate priorities is low-latency voice AI. We believe the next frontier of patient engagement is making technology so natural that the technology itself becomes almost invisible. Patients should be able to speak to their healthcare provider in their own language, receive an immediate, intelligent response and complete meaningful tasks without navigating complex digital interfaces. This has profound implications for digital inclusion. For people who struggle with literacy, language or digital confidence, voice can help remove barriers that conventional patient portals inadvertently create.

Our ambition is to combine the sophistication of advanced AI with the rigour of clinical safety, governance and human oversight.

Ultimately, the most meaningful AI innovation is not necessarily the most complex. It is the one that makes essential services accessible to more people.

Finally, what is your goal for EBO’s next chapter?

Our ambition is to help redefine the relationship between people and healthcare through AI. We believe healthcare should be accessible, inclusive and responsive to the needs of every individual, regardless of their language, digital literacy or circumstances. By combining intelligent automation with deep clinical integration, we want to remove the friction that too often separates patients from care, while giving healthcare professionals more time to focus on what matters most: the human dimension of medicine.

That vision is now matched by the resources and capabilities to deliver it at scale. Our recent investment, growing international presence and continued development of the EBO platform provide the foundations to bring technologies already delivering measurable value in the NHS to more healthcare organisations, clinical pathways and health systems internationally. For us, growth is not simply about entering new markets. It is about replicating meaningful improvements in patient access, service efficiency and clinical capacity.

I believe technology should amplify human potential and serve a wider social purpose. In healthcare, that means making it easier for people to reach the support they need and helping professionals devote more of their time to care.

Our responsibility as we grow is to keep that purpose connected to delivery. The measure of our progress will be the improvements we can sustain in real services, and the difference those improvements make to the people using them.